Loading...
Pulmonx Corporation
LUNG•NASDAQ
Healthcare
Medical - Devices
$3.34
$0.02(0.75%)
Pulmonx Corporation (LUNG) Financial Performance & Income Statement Overview
Review Pulmonx Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
22.008%
↑ 22.008%
Operating Income Growth
6.83%
↑ 6.83%
Net Income Growth
7.31%
↑ 7.31%
Operating Cash Flow Growth
16.15%
↑ 16.15%
Operating Margin
-66.00%
↓ 66.00%
Gross Margin
73.58%
↑ 73.58%
Net Profit Margin
-65.27%
↓ 65.27%
ROE
-63.69%
↓ 63.69%
ROIC
-45.89%
↓ 45.89%
Pulmonx Corporation (LUNG) Income Statement & Financial Overview
Review Pulmonx Corporation's (LUNG) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $22.54M | $23.77M | $20.39M | $20.78M |
| Cost of Revenue | $6.20M | $6.08M | $5.36M | $5.48M |
| Gross Profit | $16.34M | $17.69M | $15.03M | $15.31M |
| Gross Profit Ratio | $0.73 | $0.74 | $0.74 | $0.74 |
| R&D Expenses | $4.76M | $5.72M | $3.74M | $3.90M |
| SG&A Expenses | $26.15M | $27.11M | $25.41M | $25.31M |
| Operating Expenses | $30.91M | $32.82M | $29.16M | $29.21M |
| Total Costs & Expenses | $37.10M | $38.90M | $34.52M | $34.69M |
| Interest Income | $864000.00 | $1.04M | $1.27M | $1.31M |
| Interest Expense | $781000.00 | $842000.00 | $891000.00 | $891000.00 |
| Depreciation & Amortization | $531000.00 | $194000.00 | $376000.00 | $400000.00 |
| EBITDA | -$14.56M | -$18.91M | -$12.69M | -$13.95M |
| EBITDA Ratio | -$0.65 | -$0.80 | -$0.62 | -$0.67 |
| Operating Income | -$14.56M | -$15.13M | -$14.13M | -$13.90M |
| Operating Income Ratio | -$0.65 | -$0.64 | -$0.69 | -$0.67 |
| Other Income/Expenses (Net) | $250000.00 | $280000.00 | $177000.00 | $380000.00 |
| Income Before Tax | -$14.31M | -$13.14M | -$13.95M | -$15.24M |
| Income Before Tax Ratio | -$0.64 | -$0.55 | -$0.68 | -$0.73 |
| Income Tax Expense | $135000.00 | $38000.00 | $192000.00 | $84000.00 |
| Net Income | -$14.45M | -$13.18M | -$14.14M | -$15.33M |
| Net Income Ratio | -$0.64 | -$0.55 | -$0.69 | -$0.74 |
| EPS | -$0.36 | -$0.33 | -$0.36 | -$0.39 |
| Diluted EPS | -$0.36 | -$0.33 | -$0.36 | -$0.39 |
| Weighted Avg Shares Outstanding | $39.95M | $39.11M | $39.28M | $38.94M |
| Weighted Avg Shares Outstanding (Diluted) | $39.95M | $39.11M | $39.28M | $38.94M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan